Prophylactic Agents for Venous Thrombosis in Elective Hip Surgery: Meta-analysis of Studies Using Venographic Assessment

Archives of Internal Medicine

Volumn 153, Issue 19, 1993, Pages 2221-2228

  Mohr, David N ^a   Silverstein, Marc D ^a   Murtaugh, Paul A ^a   Harrison, Jay M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXTRAN; DIHYDROERGOTAMINE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; COMPRESSION THERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; HIP ARTHROPLASTY; HUMAN; LEG COMPRESSION; LEG THROMBOSIS; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROPHYLAXIS;

ANTICOAGULANTS; DRUG THERAPY, COMBINATION; HIP PROSTHESIS; HUMAN; PHLEBOGRAPHY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURGICAL PROCEDURES, ELECTIVE; THROMBOPHLEBITIS;

EID: 0027484513     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1993.00410190057007     Document Type: Article

References (45)

1. Sorensen JV, Borris LC, Lassen MR, et al. Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis: influence of prophylaxis with a low molecular weight heparin. Thromb Res. 1990; 59:131-138.
2. Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery: risk factors, prophylaxis, and diagnosis. Clin Orthop. 1989;242:212-231.
3. Hirsh J, Levine M. Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. Br J Clin Pract Symp Suppl. 1989;65: 2-8.
4. Gent M, Roberts RS. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest. 1985;89:396S-400S.
5. O’Meara PM, Kaufman EE. Prophylaxis for venous thromboembolism in total hip arthroplasty: a review. Orthopedics. 1990;13:173-178.
6. Paiement GD, Bell D, Wessinger SJ, Harris WH. New advances in the prevention, diagnosis, and cost effectiveness of venous thromboembolic disease in patients with total hip replacement. Hip. 1987;14:94-119.
7. Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977;297:1246-1249.
8. Harris WH, Athanasoulis C, Waltman AC, Salzman EW. Cuff-impedance phlebography and 125I fibrinogen scanning versus roentgenographic phlebography for diagnosis of thrombophlebitis following hip surgery: a preliminary report. J Bone Joint Surg Am. 1976;58:939-944.
9. Sautter RD, Larson DE, Bhattacharyya SK, et al. The limited utility of fibrinogen I 125 leg scanning. Arch Intern Med. 1979;139:148-153.
10. Suomalainen O, Kettunen K, Rissanen V, Länsimies E, Tanska S. The 125I-labelled fibrinogen uptake test in elective hip surgery. Ann Clin Res. 1985;17: 24-26.
11. LeMoine JR, Moser KM. Leg scanning with radioisotope-labeled fibrinogen in patients undergoing hip surgery: comparison with contrast phlebography and lung scans. JAMA. 1980;243:2035-2037.
12. Comerota AJ. Katz ML, Grossi RJ, et al. The comparative value of noninvasive testing for diagnosis and surveillance of deep vein thrombosis. J Vasc Surg. 1988;7:40-49.
13. Paiement G, Wessinger SJ, Waltman AC, Harris WH. Surveillance of deep vein thrombosis in asymptomatic total hip replacement patients: impedance phlebography and fibrinogen scanning versus roentgenographic phlebography. Am J Surg. 1988;155:400-404.
14. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318:1162-1173.
15. Hull RD, Raskob GE, Gent M, et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA. 1990:263:2313-2317.
16. Levine MN, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med. 1991;114:545-551.
17. Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med. 1989;149:771-774.
18. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925-929.
19. Francis CW, Pellegrini VD, Marder VJ, et al. Prevention of venous thrombosis after total hip arthroplasty: antithrombin III and low-dose heparin compared with dextran 40. J Bone Joint Surg Am. 1989;71:327-335.
20. Sautter RD, Koch EL, Myers WO, et al. Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement. JAMA. 1983;250:2649-2654.
21. Kleinbaum DG. Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982.
22. Fredin HO, Rosberg B, Arborelius M Jr, Nylander G. On thrombo-embolism after total hip replacement in epidural analgesia: a controlled study of dextran 70 and low-dose heparin combined with dihydroergotamine. Br J Surg. 1984; 71:58-60.
23. Ishak MA, Morley KD. Deep venous thrombosis after total hip arthroplasty: a prospective controlled study to determine the prophylactic effect of graded pressure stockings. Br J Surg. 1982;68:429-432.
24. Fredin H, Bergqvist D, Cederholm C, Lindblad B, Nyman U. Thromboprophylaxis in hip arthroplasty: dextran with graded compression or preoperative dextran compared in 150 patients. Acta Orthop Scand. 1989;60:678-681.
25. Leyvraz P, Bachmann F, Vuilleumier B, Berthet S, Bohnet J, Haller E. Adjusted subcutaneous heparin versus heparin plus dihydroergotamine in prevention of deep vein thrombosis after total hip arthroplasty. J Arthroplasty. 1988;3:81-86.
26. Paiement G, Wessinger SJ, Waltman AC, Harris WH. Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty. 1987;2:23-26.
27. Dechavanne M, Ville D, Berruyer M, et al. Randomized trial of a low-molecularweight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis. 1989;1:5-12.
28. Harris WH, Salzman EW. Athanasoulis C, Waltman AC, Baum S, DeSanctis RW. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg Am. 1974;56:1552-1562.
29. Kaempffe FA, Lifeso RM, Meinking C. Intermittent pneumatic compression versus Coumadin: prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop. 1991;269:89-97.
30. Beisaw NE, Comerota AJ, Groth HE, et al. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. J Bone Joint Surg Am. 1988;70:2-10.
31. Gallus A, Raman K, Darby T. Venous thrombosis after elective hip replacement: the influence of preventive intermittent calf compression and of surgical technique. Br J Surg. 1983;70:17-19.
32. Leyvraz PF, Richard J, Bachmann F, et al. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 1983;309:954-958.
33. Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S. Two-step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding. JAMA. 1983;249:374-378.
34. Harris WH, Athanasoulis CA, Waltman AC, Salzman EW. Prophylaxis of deepvein thrombosis after total hip replacement: dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily. J Bone Joint Surg Am. 1985;67:57-62.
35. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost. 1988;60:407-410.
36. The Danish Enoxaparin Study Group. Low-molecular-weight heparin (enoxaparin) vs Dextran 70: the prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med. 1991;151:1621-1624.
37. Lassen MR, Borris LC, Christiansen HM, et al. Prevention of thromboembolism in 190 hip arthroplasties: comparison of LMW heparin and placebo. Acta Orthop Scand. 1991;62:33-38.
38. Eriksson BI, Kälebo P, Anthmyr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement: comparison of low-molecular-weight heparin and unfractionated heparin. J Bone Joint Surg Am. 1991;73:484-493.
39. Kakkar VV, Stamatakis JD, Bentley PG, Lawrence D, de Haas HA, Ward VP. Prophylaxis for postoperative deep-vein thrombosis: synergistic effect of heparin and dihydroergotamine. JAMA. 1979;241:39-42.
40. Turpie AGG. Enoxaparin prophylaxis in elective hip surgery. Acta Chir Scand Suppl. 1990;556:103-107.
41. Agnelli G, Cosmi B, Ranucci V, et al. Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery: a venographycontrolled study. Arch Intern Med. 1991;151:2167-2171.
42. DiSerio FJ, Parno J, Singer JM. Limitation of impedance plethysmography in assessing efficacy of dihydroergotamine-heparin prophylaxis of deep vein thrombosis. Thromb Res. 1985;37:449-458.
43. Woolson ST, McCrory DW, Walter JF, Maloney WJ, Watt JM, Cahill PD. B-mode ultrasound scanning in the detection of proximal venous thrombosis after total hip replacement. J Bone Joint Surg Am. 1990;72:983-987.
44. Borris LC, Christiansen HM, Lassen MR, Olsen AD, Schott P. Comparison of real-time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. Thromb Haemost. 1989;61:363-365.
45. Barnes RW, Nix ML, Barnes CL, et al. Perioperative asymptomatic venous thrombosis: role of duplex scanning versus venography. J Vasc Surg. 1989;9: 251-259.